Austco Healthcare (ASX:AHC) expects fiscal year 2026 revenue in the range of AU$90 million to AU$95 million, up 11% to 17% on fiscal year 2025 revenue of AU$81.4 million, according to a Monday Australian bourse filing.
The company sees earnings before interest, taxes, depreciation, and amortization (EBITDA) in the range of AU$14 million to AU$14.6 million, up 7% to 12%, and EBITDA margin up almost 16%.
The company said it has continued sales momentum across all regions, underpinned by new contract wins in New Zealand, Australia, Canada, and the US.
The company's shares fell 18% in recent Monday trade, their lowest since late 2024.